Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-007486

Options or other derivatives

  • General Counsel acquired 116,226 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Wilson Martin General Counsel 2023-02-14 Grant or award · Stock Option (Right to Buy) +87,147 87,147 D
Wilson Martin General Counsel 2023-02-14 Grant or award · Restricted Stock Units +29,079 29,079 D
Loading xslF345X03/form4.xml…